Bard books positive Q4
C. R. Bard has reported a rise in net income for its unaudited financial results of its 2008 fourth quarter, which ended Dec. 31, 2008.
Net income for the quarter was $149.4 million, compared to $105.2 million in the same quarter last year. For the full year 2008, net income was $416.5 million, compared to full year 2007 results of $406.4 million.
For the quarter, net sales were $634.2 million, an increase of 9 percent over the prior-year period earning of $583.3 million. In the United States, net sales were $436.3 million and net sales outside the U.S. were $197.9 million, compared to the prior-year periods, according to the Murray Hill, N.J.-based Bard.
Within its product groups, its vascular segment saw higher sales in the fourth quarter, reaching $168.5 million, compared to $141.9 million in the same period last year.
Meanwhile, its surgical specialties group saw a slight downtick in sale, booking $95.5 million in the 2008 fourth quarter compared to $96.5 million last year, according to the company.
Net income for the quarter was $149.4 million, compared to $105.2 million in the same quarter last year. For the full year 2008, net income was $416.5 million, compared to full year 2007 results of $406.4 million.
For the quarter, net sales were $634.2 million, an increase of 9 percent over the prior-year period earning of $583.3 million. In the United States, net sales were $436.3 million and net sales outside the U.S. were $197.9 million, compared to the prior-year periods, according to the Murray Hill, N.J.-based Bard.
Within its product groups, its vascular segment saw higher sales in the fourth quarter, reaching $168.5 million, compared to $141.9 million in the same period last year.
Meanwhile, its surgical specialties group saw a slight downtick in sale, booking $95.5 million in the 2008 fourth quarter compared to $96.5 million last year, according to the company.